{"disease":{"id":"epilepsy-tonic-clonic","name":"epilepsy tonic clonic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07287163","title":"Clinical Trial of Vormatrigine in Adult Patients With Epilepsy","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":700,"lead_sponsor_name":"Praxis Precision Medicines","has_results":false},{"nct_id":"NCT01463306","title":"A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":605,"lead_sponsor_name":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","has_results":true},{"nct_id":"NCT05059002","title":"EpiWatch: Evaluation of a Non-EEG Physiological Signal Based Seizure Monitoring System","phase":"NA","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"EpiWatch, Inc.","has_results":false},{"nct_id":"NCT04252846","title":"A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy","phase":"","overall_status":"COMPLETED","enrollment_count":191,"lead_sponsor_name":"Eisai Limited","has_results":false},{"nct_id":"NCT00043901","title":"Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04770337","title":"Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy","phase":"NA","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Neuroelectrics Corporation","has_results":false},{"nct_id":"NCT00150813","title":"Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"UCB Pharma SA","has_results":true},{"nct_id":"NCT03446664","title":"Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"LivaNova","has_results":false},{"nct_id":"NCT06967012","title":"A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Affiliated Hospital of Nantong University","has_results":false},{"nct_id":"NCT03831802","title":"Embrace and Quality of Life","phase":"NA","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"Centre Hospitalier Universitaire Vaudois","has_results":false},{"nct_id":"NCT01439438","title":"Topiramate Bioequivalence Study Brazil - Fast","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03443388","title":"Novel Helmet Design in Patients With Seizures","phase":"NA","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Michael A. Gelfand, MD, PhD","has_results":true},{"nct_id":"NCT04282681","title":"XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"LivaNova","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}